Alendronate Therapy and Renal Insufficiency: A Prescription for Problems?

Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Alendronate Therapy and Renal Insufficiency: A Prescription for Problems?
Author(s)
Hayes BS
LAvezo LA
Parsons RB

Article PDF
023070017.pdf
Author and Disclosure Information

Brandon S. Hayes, PharmD, Laurence A. Lavezo, PharmD, and Robert B. Parsons, MD

At the time of this study, Dr. Hayes was a pharmacy practice resident at the New Mexico VA Health Care System (NMVAHCS) in Albuquerque. He is currently a primary care clinical pharmacist at the VA Great Lakes Health Care System in Tomah, WI. Dr. Lavezo is a primary care clinical pharmacist and Dr. Parsons is an attending physician in the internal medicine service, both at the NMVAHCS.

Issue
Federal Practitioner - 23(7)
Publications
Federal Practitioner
Topics
Geriatrics
Nephrology
Page Number
17
Legacy Keywords
alendronate, therapy, kidney, osteoporosis, renal, insufficiency, prescription, problems, adverse drug effects, bone health, study, bisphosphonate, FDAalendronate, therapy, kidney, osteoporosis, renal, insufficiency, prescription, problems, adverse drug effects, bone health, study, bisphosphonate, FDA
Sections
Clinical Review
Author(s)
Hayes BS
LAvezo LA
Parsons RB
Author(s)
Hayes BS
LAvezo LA
Parsons RB
Author and Disclosure Information

Brandon S. Hayes, PharmD, Laurence A. Lavezo, PharmD, and Robert B. Parsons, MD

At the time of this study, Dr. Hayes was a pharmacy practice resident at the New Mexico VA Health Care System (NMVAHCS) in Albuquerque. He is currently a primary care clinical pharmacist at the VA Great Lakes Health Care System in Tomah, WI. Dr. Lavezo is a primary care clinical pharmacist and Dr. Parsons is an attending physician in the internal medicine service, both at the NMVAHCS.

Author and Disclosure Information

Brandon S. Hayes, PharmD, Laurence A. Lavezo, PharmD, and Robert B. Parsons, MD

At the time of this study, Dr. Hayes was a pharmacy practice resident at the New Mexico VA Health Care System (NMVAHCS) in Albuquerque. He is currently a primary care clinical pharmacist at the VA Great Lakes Health Care System in Tomah, WI. Dr. Lavezo is a primary care clinical pharmacist and Dr. Parsons is an attending physician in the internal medicine service, both at the NMVAHCS.

Article PDF
023070017.pdf
Article PDF
023070017.pdf

Issue
Federal Practitioner - 23(7)
Issue
Federal Practitioner - 23(7)
Page Number
17
Page Number
17
Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
Geriatrics
Nephrology
Article Type
Article
Display Headline
Alendronate Therapy and Renal Insufficiency: A Prescription for Problems?
Display Headline
Alendronate Therapy and Renal Insufficiency: A Prescription for Problems?
Legacy Keywords
alendronate, therapy, kidney, osteoporosis, renal, insufficiency, prescription, problems, adverse drug effects, bone health, study, bisphosphonate, FDAalendronate, therapy, kidney, osteoporosis, renal, insufficiency, prescription, problems, adverse drug effects, bone health, study, bisphosphonate, FDA
Legacy Keywords
alendronate, therapy, kidney, osteoporosis, renal, insufficiency, prescription, problems, adverse drug effects, bone health, study, bisphosphonate, FDAalendronate, therapy, kidney, osteoporosis, renal, insufficiency, prescription, problems, adverse drug effects, bone health, study, bisphosphonate, FDA
Sections
Clinical Review
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Hayes BS